← Back to catalogue

EEG-1260A Neurofax System; JE-940A EEG Amplifier Unit; LS-940A Photic Stimulator

FDA 510(k)EUDAMED

Class II (US FDA 510(k))

510(k) K251366Ref JE-940AK

by Nihon Kohden Corporation

Identity

Trade Name
EEG Amplifier Unit JE-940A EUDAMED
Device Name
Electroencephalograph EUDAMED
Model / Reference
JE-940AK EUDAMED

Identifiers

Primary DI / UDI-DI
04931921023143 EUDAMED
Basic UDI-DI
4931921MD2a0014LQ EUDAMED
510(k) Number
K251366 FDA 510(k)
FDA Product Code
OLT FDA 510(k)
EMDN Code
Z12100302 ELECTROENCEPHALOGRAPHS EUDAMED
Models / Variants

Classification

Device Class
Class IIa EUDAMED
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 882.1400 FDA 510(k)
Regulation Number
882.1400 FDA 510(k)
Market of Registration
Germany EUDAMED
Advisory Committee
Neurology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

Clinical & Handling

Sterile

No

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

Yes

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

The EEG-1260A Neurofax System is a Non-Normalizing Quantitative Electroencephalograph Software designed to record and display electroencephalogram (EEG) waveforms and related vital signals. It integrates with the JE-940A EEG Amplifier Unit to acquire biological signals such as EEG, ECG, EMG, respiration, and photic stimulation responses for diagnostic assessment. The LS-940A Photic Stimulator is included as a component for standardized visual stimulation during EEG monitoring.

This system is intended for clinical use in neurology settings, featuring reusable hardware components with FDA 510(k) clearance and EU MDR compliance. The EEG-1260A and JE-940A units are non-sterile, reusable medical devices, while the LS-940A Photic Stimulator is supplied as part of the system. No MRI safety classifications or single-use specifications are indicated in the regulatory data. Storage and handling follow standard medical device protocols as defined by the manufacturer.

Frequently asked questions

What types of biological signals can the EEG-1260A Neurofax System record and analyze, and how does it integrate with other components for diagnostic use?

The EEG-1260A Neurofax System is designed to record and display electroencephalogram (EEG) waveforms alongside other vital signals such as ECG, EMG, respiration, and photic stimulation responses. It integrates with the JE-940A EEG Amplifier Unit to acquire these signals for diagnostic assessment. The LS-940A Photic Stimulator is included as part of the system to provide standardized visual stimulation during EEG monitoring, ensuring comprehensive evaluation of neurological function.

Are the hardware components of this system reusable or single-use, and what does that mean for maintenance and cost?

The EEG-1260A Neurofax System and JE-940A EEG Amplifier Unit are explicitly labeled as non-sterile, reusable medical devices, meaning they are intended for repeated use in clinical settings after proper cleaning and maintenance. This design reduces per-procedure costs but requires adherence to manufacturer guidelines for disinfection and upkeep. The LS-940A Photic Stimulator is supplied as part of the system and is not separately classified as reusable or single-use in the provided data.

What regulatory pathways have this device undergone, and how does that affect its use in clinical settings?

The EEG-1260A Neurofax System has undergone FDA 510(k) clearance and EU MDR compliance, confirming its safety and performance for clinical use in neurology settings. The system was determined substantially equivalent to a predicate device by the FDA’s Neurology Advisory Committee (NE), and its classification as a Class II device (per OpenFDA data) reflects its moderate-risk designation. These pathways ensure the device meets stringent regulatory standards for diagnostic accuracy and patient safety.

How should the system be stored, and are there any special handling instructions provided by the manufacturer?

While the data does not specify exact storage conditions, standard medical device protocols apply for the EEG-1260A Neurofax System and its components. The reusable hardware (EEG-1260A and JE-940A) should be stored in a clean, dry environment protected from physical damage or contamination. The manufacturer’s guidelines—though not detailed here—likely include instructions for proper disinfection between uses and secure storage to maintain functionality. Always refer to the manufacturer’s instructions for precise handling.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: EEG System (1260A) - NIHON KOHDEN GLOBAL, EEG-1260A Neurofax System (EEG-1260A); JE-940A EEG Amplifier Unit (JE ..., EEG-1260A Neurofax System (EEG-1260A); JE-940A EEG… - FDA.report

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (2)

  • FDA 510(k) K251366 24 fields · synced Oct 6, 2026
  • EUDAMED 46f312f1-4f5f-4fb4-9216-ebd3d3d5b4dd 61 fields · synced Jul 15, 2026